May 25, 2018· Comment from The National Community Pharmacists Association (NCPA)· FDA-2018-D-1067-0058
Filed on regulations.gov — full text not in the inline record.
FDANonrulemakingFDA-2018-D-1067
Evaluation of Bulk Drug Substances Nominated for Use in Compounding Under Section 503B of the Federal Food, Drug, and Cosmetic Act
RIN
—
Last modified
Sep 7, 2022
Comment window
closed 3086d ago
National Community Pharmacists Association filings
1
Activity
National Community Pharmacists Association filed 1 comment on this docket between May 25, 2018 and May 25, 2018. 2 other organizations filed here. The comment window closed 3086d ago.
What National Community Pharmacists Association filed (1)
Abstract
No abstract recorded.
View on regulations.gov →Co-filers (2)
See everyone who commented →- National Community Pharmacists AssociationTHIS ORG1 filing · confidence 97%
- American Medical Associationtrade assoc.1 filing · confidence 97%
- Association for Accessible Medicinestrade assoc.1 filing · confidence 97%